Condition
Thrombocytopathy
Total Trials
6
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown3
Withdrawn1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05985668Recruiting
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05654766Unknown
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT00182156Withdrawn
Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD
NCT01344096Unknown
Thrombocytopathy in Gaucher Disease Patients
NCT02461329Not ApplicableUnknown
Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy
NCT01935245Not ApplicableCompletedPrimary
Platelet Function in Minimal Extracorporeal Circulation in CABG
Showing all 6 trials